Osiris Therapeutics Inc.
Shares rose $1.60, or 16 percent, to $11.84 after the Columbia-based developer of treatments using adult stem cells said its experimental drug Chondrogen eased arthritis pain in the knee.
Stock of interest
The Baltimore Sun
Copyright
© 2021, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad